NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,761.00+₹3.50 (+0.2%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.97% below the high.
Loading market information…
BSE · METSL.BO · INR
Stock price, dividends
Quote as of Oct 29, 2026, 09:49 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Maestros Electronics & Telecommunications Systems Limited’s quoted price sits in the lower half of its reported 52-week range, 54.03% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Maestros Electronics & Telecommunications Systems Limited’s forward annual dividend is ₹0.50 per share, paid semi-annual. The forward yield is 0.64% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
Maestros Electronics and Telecommunications Systems Ltd. (METSL) focuses on the innovation and fabrication of integrated medical devices. The company's activities are organized into two primary divisions: the Electronics and Telecommunication Instrument (ET) segment, which supplies industrial panel printers, and the Telemedicine Instrument segment, dedicated to the distribution of various healthcare items. Balkrishna Tendulkar founded the company in 2005, and its corporate headquarters are situated in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,761.00+₹3.50 (+0.2%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.97% below the high.
₹9,664.00+₹105.50 (+1.1%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.78% below the high.
₹4,580.00+₹23.00 (+0.5%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.76% below the high.
₹2,244.00+₹62.10 (+2.85%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
₹681.75-₹7.95 (-1.15%)
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 5.97% below the high.
₹1,184.40+₹8.90 (+0.76%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 3.87% below the high.
₹177.00-₹0.79 (-0.44%)
QMS Medical Allied Services Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.35% below the high.
₹102.50-₹0.49 (-0.48%)
Raaj Medisafe India Limited’s quoted price sits in the upper half of its reported 52-week range, 7.57% below the high.
